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Abstract From human PBMC stimulated with PHA, we have 
isolated cDNA clones encoding a novel cytokine named SCM-1, 
which is significantly related to the CC and the CXC chemokines 
but has only the 2nd and the 4th of the four cysteines conserved 
in these proteins. Its gene is also distinctly mapped to human 
chromosome 1. SCM-I is strongly induced in human PBMC and 
Jurkat T cells by PHA stimulation. Among various human tis- 
sues, SCM-1 is expressed most strongly in spleen. SCM-1 is 
found to be 60.5% identical to lymphotactin, a recently described 
murine lymphocyte-specific chemokine, which also retains only 
two cysteines. SCM-1 and lymphotactin may thus represent he 
human and murine prototypes of a novel C or ~/type chemokine 
family. 
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may thus represent the human and murine prototypes of a new 
C or 2' type chemokine family. 
2. Materials and methods 
2.1. Cells and ~Ttokines 
PBMC were isolated from heparinized whole blood from healthy 
donors by using Ficoll-Paque (Pharmacia) and cultured in the presence 
of PHA-M (Gibco) at a 1 : 100 dilution. Raji (a human B cell line), 
Jurkat (a human T cell line) and U937 (a human monocytoid cell line) 
were used. Recombinant TNF-~, IFN-~,, IL-I~, and IL-4 were pur- 
chased from Genzyme (Cambridge, MA). The cDNA for human MIP- 
I n [4] was cloned from a library generated from human PBMC stimu- 
lated with PHA (see below) by polymerase chain reaction (PCR) [5] 
using specific primers (5'-ATCATGCAGGTCTCCA-CTGCT-3' and 
5'-CCCTCAGGCACTCAGCTCTAG-3'). The identity of the cDNA 
was confirmed by DNA sequencing using T7 Sequencing kit (Pharma- 
cia). 
1. Introduction 
Emigration of leukocytes from blood into sites of inflamma- 
tion and immune responses is essential for the host defense 
mechanisms. It is now known that a number of inducible cyto- 
kines collectively called as chemokines regulate migratory re- 
sponses of leukocytes. From the arrangement of the first two 
of the four conserved cysteines, chemokines are grouped into 
two major families, the CXC or ~ family and the CC or fl 
family. In CXC chemokines, the first two cysteines are sepa- 
rated by a single amino acid. The genes for these proteins are 
clustered in q12-21 region of human chromosome 4. They are 
potent chemoattractants for neutrophils. In CC chemokines, 
the first two cysteines are adjacent. The genes of this family are 
clustered on human chromosome 17. They are potent chemoat- 
tractants for monocytes (for review, see [1,2]). Recently, a novel 
chemokine named lymphotactin was identified from activated 
mouse pro-T cells [3]. Lymphotactin is unique because it has 
only two, the 2nd and the 4th, of the four cysteines conserved 
in other chemokines and also a C-terminal sequence much 
longer than those of other chemokines. In the present study, we 
have identified a novel human cytokine, SCM-1. The cDNA 
clones were isolated from PHA-stimulated PBMC. SCM-1 is 
significantly related to the CC chemokines but, like mouse 
lymphotactin, has only two instead of four cysteines and a 
C-terminal region much longer than those of other chemokines. 
In fact, SCM-1 is 60.5% identical to murine lymphotactin and 
may well be its human homologue. SCM-1 and lymphotactin 
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The nucleotide sequence data have been deposited in DDBJ/EMBL/ 
GenBank under the accession umbers of D43768 and D43769. 
2.2. Signal sequence trap 
Novel cDNA fragments were initially isolated by a modified method 
of signal sequence trap [6] (lmai et al., to be described elsewhere). In 
brief, poly(A) ÷ RNA prepared from human PBMC stimulated with 
PHA for 72 h was converted to cDNA by using random primers (cDNA 
Synthesis Kit, Pharmacia). Oligo(dC) tails were added to the 3' ends of 
cDNA by using terminal deoxynucleotidyl transferase (Gibco/BRL). 
The second strands were synthesized by using oligo(dG) primers carry- 
ing a unique sequence and a Sail site. After sonication, cDNA frag- 
ments of about 300 base pairs (bp) were gel-purified, blunted and 
ligated to an adaptor carrying aunique sequence and an XbaI site. The 
5'-portion-enriched cDNA fragments were amplified by PCR [5] using 
universal amplification primers, double-digested with SalI and XbaI, 
and inserted between the promoter for EF-I~ [7] and the coding se- 
quence of CD4 (without he signal sequence) in an expression vector 
pDREF (Imai et al., to be described elsewhere). Raji cells were trans- 
fected with the cDNA library by electroporation using a GenePulser 
(Bio-Rad) and cultured under hygromycine selection. After three con- 
secutive sortings, about 40% of cells were positive for surface CD4. 
Plasmid DNAs were recovered from these cells and transfected into E. 
coli. Plasmid clones prepared from 100 random transformants were 
then separately transfected into Raji and 42 clones were found to induce 
surface xpression of CD4. Sequences of the inserted DNA fragments 
were determined by using AutoRead Sequencing kit and A.L.F. DNA 
Sequencer (Pharmacia), and compared in the GenBank database for 
homology. A novel cDNA fragment TY53 with significant homology 
to chemokines was selected for further study. 
2.3. Isolation of full-length eDNA 
Double-stranded cDNAs were synthesized from poly(A) ÷ RNA pre- 
pared from PBMC stimulated with PHA for 72 h by using Superscript 
cDNA Synthesis kit (Gibco/BRL). cDNAs longer than 1 kb were in- 
serted into pSPORT (Gibco/BRL) and transfected into E. coli DH10B 
by using a GenePulser (Bio-Rad). The library consisting of about 
5 × 105 independent clones was screened with the TY53 eDNA and 
three independent clones were isolated. Two clones (0.5 kb and 1.2 kb) 
were completely sequenced from both sides by using AutoRead Se- 
quencing kit and A.L.F. DNA Sequencer (Pharmacia). The other 0.5 
kb clone was partially sequenced. 
2.4. Southern and Northern blot analysis 
Filters for Zoo blot and Multiple Tissue Northern blots were pur- 
chased from Clontech. Poly(A) ÷ RNAs prepared from various cell 
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sources were fractionated by electrophoresis on 1% agarose gel contain- 
ing formaldehyde and blotted to a filter membrane (Hybond N ÷) 
(Amersham). Filters were hybridized with probes labeled with 32p using 
Multiprime DNA labeling system (Amersham) and subjected to autora- 
diography. 
2.5. Chromosomal ssignment 
Genomic DNAs derived from human-rodent somatic ell hybrids 
were purchased from BIOS Lab. The presence of human SCM-1 gene 
in 100 ng of DNA from each hybrid was examined by PCR using a set 
of primers for human SCM-1 (5'-GTCTCAGATAAGAGGACCTG- 
3' and 5'-GTGGCTTGTGGATCAGCACA-Y) that specifically ampli- 
fies 900 bp bands from human DNA but not from hamster or mouse 
DNA. Discordance is expressed as a percentage of cases in which the 
gene is detectable and a chromosome is absent and vice versa, and the 
values equal or less than 10% are considered significant for gene assign- 
ment. 
3. Results 
3.1. Molecular cloning of  human SCM-1 cDNA 
Signal sequence trap is a newly introduced technique aiming 
at selective isolation of 5' portion fragments of cDNA species 
encoding secretory and type I integral membrane proteins [6]. 
A modified signal sequence trapping method (Imai et al., to be 
described elsewhere) was applied for isolation of cDNA frag- 
ments from PHA-stimulated human PBMC. Among a number 
of novel cDNA fragments, we noted that TY53 was translata- 
ble to a polypeptide showing homologies to chemokines. Inter- 
estingly, however, the peptide had only the 2nd of the two 
cysteines that are regularly found in the N-terminal region of 
chemokines in a motif of CXC or CC [1,2]. TY53 might, there- 
fore, represent a new type of chemokine having a single C 
motif. We thus decided to isolate the full-length cDNA of TY53 
from a library generated from PHA-stimulated PBMC. 
By using TY53 as a probe, we isolated three independent 
cDNA clones, two 0.5 kb clones and one 1.2 kb clone. Their 
nucleotide sequences overlap and encode the same polypeptide 
(Fig. 1A). The 3' non-coding regions differ in length (188 bp 
and 860 bp) probably because of alternative uses of poly(A) 
signals. The longer 3' non-coding sequence contains a single 
mRNA destabilization signal (UUAUUUAUU)[8],  which is 
frequently observed in cytokine genes. From the size of hy- 
bridizing bands detected in Northern blot analysis (about 0.8 
kb) (see below), the major transcripts may carry the shorter 
3'-non-coding sequence. 
The open reading frame starts from the first ATG which 
conforms well to the Kozak rule [9] and encodes a polypeptide 
of 114 amino acids. The predicted protein has a highly hydro- 
phobic N-terminus characteristic of a leader sequence. From 
von Heijne's rule [10], the mature protein probably starts from 
valine-22 after cleavage of the signal peptide. This putative 
mature protein is quite hydrophilic, of a molecular weight of 
10,271, and rich in basic amino acids with an isoelectric point 
of 11.1. No potential N-linked glycosylation site is found. Com- 
puter analysis revealed that the protein sequence of TY53 is 
related to a class of cytokines collectively called as chemokines 
and especially to CC chemokines. Fig. 1B shows the alignment 
of SCM-1 with RANTES (a CC chemokine) and IL-8 (a CXC 
chemokine). All the known chemokines have four conserved 
cysteines with the N-terminal two cysteines in either the CC 
motif or the CXC motif. Disulphide bonds are formed between 
the I st and 3rd cysteines and the 2nd and the 4th cysteines [1,2]. 
Importantly, the TY53 protein carries only the 2nd and the 4th 
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Fig. 1. (A) Nucleotide sequences and the predicted amino acid sequence 
of the SCM-1 cDNA clones. The probable cleavage site of the signal 
sequence is indicated by arrowhead. The polyadenylation signals are 
indicated by dotted lines. The alternative 3'end of cDNA is indicated 
by arrow. The mRNA destabilization signal is enclosed. The nucleotide 
sequence of the human SCM-1 cDNA is available from DDBJ/Gen- 
Bank/EMBL under accession umber of D43768. (B) Alignment of 
SCM-1 with RANTES (a CC chemokine) and IL-8 (a CXC cbemo- 
kine). Gaps are introduced for the maximal homology. Amino acids 
identical between SCM-I and RANTES and/or IL-8 are enclosed. 
(C) Alignment of lymphotactin and SCM-1. The amino acid sequence 
oflymphotactin shown in this figure is in fact deduced from our murine 
SCM-1 cDNA (the DDBJ/GenBank/EMBL accession number: 
D43769) that is essentially identical to the lymphotactin cDNA [3] with 
two nucleotide differences in the coding region. This is because the 
deduced amino acid sequence of lymphotactin i  the original report has 
a number of apparent translational mistakes [3]. The amino acid 78 
should be lysine instead of leucine. An extra glycine is found between 
amino acids 99 and 100. The amino acid at 110 should be valine instead 
ofisoleucine, which is thus possibly the only amino acid that is different 
between lymphotactin and our murine SCM-I (isoleucine at 1 i0). 
cysteines, thus presenting only the C motif and being capable 
of forming a single disulphide bond instead of two. The C- 
terminal region of TY53 is also much longer than those of other 
chemokines. We designated this cytokine as SCM-1 from Single 
Cysteine Motif-1. 
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Fig. 2. Zoo blot analysis of the SCM-I gene. The zoo blot filter (Clon- 
tech) was hybridized with 32p-labeled SCM-1 cDNA (the coding region) 
at low stringency conditions (5 x SSPE, 30% formamide, at42°C) and 
washed (2 x SSC, at room temperature). 
3.2. Southern blot analysis and chromosomal ssignment 
A Zoo blot filter was probed with the coding sequence of the 
SCM-1 cDNA (Fig. 2). Hybridizing bands were detected in 
DNAs from human and other mammalian species but not in 
those from chicken and yeast, suggesting that SCM-1 is well 
conserved among mammalian species. Chromosomal ssign- 
ment of SCM-1 gene was carried out by using a panel of so- 
matic hybrids containing known subsets of human chromo- 
somes on hamster or mouse backgrounds. As shown in Fig. 3, 
the presence of the human SCM-1 gene that was determined 
by specific PCR correlated only with hybrids containing human 
chromosome 1 with 5% discordance. It is thus concluded that 
the SCM-I gene is located on human chromosome 1.
3.3. Northern blot analysis 
Expression of SCM-1 mRNA was next studied by Northern 
blot analysis using the coding region of SCM-1 cDNA as a 
probe. Poly(A) ÷ RNA was prepared from PBMC at indicated 
time points after stimulation with PHA. As shown in Fig. 4A, 
no signals were detected in resting PBMC. Upon PHA-stimula- 
tion, transcripts of about 0.8 kb rapidly increased with a peak 
accumulation at 4 h and remained at a high level even after 72 
h. The same filter was rehybridized with a probe for human 
MIP-I~, a CC chemokine. In contrast to SCM-1, MIP-10~ tran- 
scripts were detected at a considerable vel in resting PBMC. 
After PHA-stimulation, MIP-I~ transcripts further increased 
with a peak accumulation at 4 h but returned to the basal evel 
by 72 h. Induction of SCM- 1 gene and that of MIP- 1 ~ were also 
studied in a human T cell line Jurkat and in a monocytoid cell 
line U937 (Fig. 4A). PHA-stimulation strongly induced SCM-1 
mRNA in Jurkat cells with a peak accumulation at 48 h. In 
contrast, the induction of MIP-I~ mRNA by the same treat- 
ment was quite rapid and transient with a peak level at 4 h. In 
the case of U937 cells, various cytokines, especially TNF-~ and 
IL-I~, induced the expression of MIP-Ic~ gene but not that of 
SCM-1 gene. The relatively long-lasting expression of SCM-I 
mRNA after induction, rather unique among the known che- 
mokines [1,2], may be in part related to the lack of the mRNA 
destabilization sequence in the shorter 3' non-coding region 
(Fig. 1A). 
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Fig. 3. Chromosomal mapping of the SCM-I gene. A total of 20 rodent-human somatic ell hybrids were analyzed for the presence ofthe SCM-I 
gene by using specific PCR. Karyotyping symbols are as follows: +, chromosome present in the cell line; M, chromosome present but at low frequency; 
D, chromosome present but with multiple deletions; blank, chromosome absent. D% is the percent of discordance between the presence of a 
chromosome and the PCR detection of the SCM-I gene. 
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Fig. 4. Northern blot analysis for expression of SCM-1 mRNA in comparison with that of MIP-la mRNA. (A) Induction of SCM-1 gene as well 
as that of MIP-la gene in PBMC, Jurkat (a CD4 + T cell line), and U937 (a monocytoid cell line). PBMC and Jurkat were cultured in the presence 
of PHA for indicated times. U937 cells were treated without or with IFN-7 (100 U/ml), TNF-a (70 ng/ml), IL-la (5 ng/ml), or IL-4 (1 ng/ml) for 
5 h. Poly(A) ÷ RNA (2/zg/lane) was subjected to Northern blotting analysis with 32p-labeled SCM-1 cDNA as a probe. The same filters were 
rehybridized with a probe for MIP-la as well as with that for fl-actin. (B) Multiple Tissue Northern blots filters (Clontech) were hybridized with 
~2P-labeled SCM-1 cDNA. The same filters were rehybridized with a probe for MIP-lc~ as well as with that for fl-actin. 
The expression of SCM-1 in various human tissues was next 
studied by using Multiple Tissue Northern blots filters. As 
shown in Fig. 4B, SCM- 1 mRNA is most abundantly expressed 
in spleen. Expression is also seen in peripheral leukocytes (PBL) 
and thymus. Very low levels of expression are detected in lung, 
colon and small intestine. The transcripts are below detection 
levels in other tissues. M IP - la  mRNA was similarly but more 
broadly detected in spleen, PBL, lung, thymus and some other 
tissues. Since we never detected SCM-1 mRNA in normal 
PBMC (Fig. 4A), the presence of SCM- 1 mRNA in PBL of the 
Multiple Tissue Northern blots may be due to induction of 
SCM-1 gene in vivo for some reasons particular to the source 
of mRNA. 
4. Discussion 
No less than 16 different human chemokines are now known. 
All the chemokines have four cysteines, forming one disulphide 
bond between the 1st and the 3rd cysteines and another one 
between the 2nd and the 4th cysteines. From the arrangement 
of the first two cysteines, chemokines are grouped into two 
major types, the CXC or a type and the CC orfl  type. The CXC 
chemokines act mainly on neutrophils, while the CC chemoki- 
nes act more broadly on monocytes, lymphocytes, basophiles 
and eosinophiles. The genes of  the CXC chemokines are clus- 
tered on human chromosome 4, while those of  the CC chemo- 
kines map to human chromosome 17 (for review, see [1,2]). In 
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the present study, we identified a new human cytokine SCM-1. 
Computer analysis hows that SCM-1 is related to the chemok- 
ines and particularly to the CC chemokines. SCM-1 is, how- 
ever, quite unique because ithas only two cysteines, the 2nd and 
the 4th, instead of four cysteines found in other chemokines. 
SCM-1 also has a C-terminal sequence much longer than those 
of other chemokines. Furthermore, the gene for SCM-1 dis- 
tinctly maps to human chromosome 1. SCM-1 may thus be a 
new C type chemokine. 
Recently, a new murine chemokine named lymphotactin was 
identified from a cDNA library derived from activated pro-T 
cells of Balb/c mouse [3]. Like SCM-1, lymphotactin has also 
only the 2nd and the 4th of the four cysteines conserved in other 
chemokines. High levels of lymphotactin mRNA were detected 
in activated CD8 + T cells from thymus and spleen as well as in 
activated CD4-CD8-TcR~fl +thymocytes. Expression of lym- 
photactin gene was not detected in any other tissues. Recombi- 
nant lymphotactin was shown to act specifically on lympho- 
cytes and not on monocytes or neutrophils. The gene encoding 
lymphotactin was mapped to the distal region of mouse chro- 
mosome 1 and not to mouse chromosome 11 where the genes 
for the murine CC chemokines are clustered or mouse chromo- 
some 5 where those for the murine CXC chemokines are prob- 
ably clustered [1,2]. These characteristics of lymphotactin are 
in fact quite similar to those of SCM-1. Furthermore, the ho- 
mology between SCM-1 and lymphotactin is 60.5% at the 
amino acid level and 70.0% at the nucleotide l vel (Fig. 1C). It 
is thus possible that SCM-1 may be the human homologue of 
murine lymphotactin. In fact, by using SCM-1 cDNA as a 
probe and from a cDNA library derived from PHA-stimulated 
Balb/c mouse spleen cells, we had already isolated the murine 
cDNA encoding putative mouse homologue of SCM-1 which 
turned out to be essentially identical to the lymphotactin cDNA 
recently reported [3]. SCM-1 and lymphotactin may thus re- 
spectively represent the human and murine prototype of a new 
C or y type chemokine family. The biochemical characteristics 
and the biological activities of SCM-1 are now under investiga- 
tion. 
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